ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 237 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $21,380,000 | -2.5% | 230,043 | -37.6% | 3.22% | +76.3% |
Q3 2021 | $21,938,000 | -0.3% | 368,399 | +14.2% | 1.82% | +2.5% |
Q2 2021 | $22,001,000 | -1.4% | 322,599 | +0.3% | 1.78% | +5.2% |
Q1 2021 | $22,320,000 | -9.2% | 321,659 | +0.5% | 1.69% | -2.4% |
Q4 2020 | $24,590,000 | -19.8% | 320,059 | -21.9% | 1.73% | -34.3% |
Q3 2020 | $30,657,000 | +34.2% | 409,905 | +13.0% | 2.64% | +25.7% |
Q2 2020 | $22,845,000 | +6781.0% | 362,900 | +4934.7% | 2.10% | +5891.4% |
Q3 2018 | $332,000 | – | 7,208 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |